Fulltext

45PCost-effectiveness analysis of VEGF-A testing to predict response to bevacizumab (BEV) as a component of neo-adjuvant therapy of early HER-2 negative breast cancer

Blank, P.R. ; Loibl, S. ; Linderholm, B.K. ; Caramuta, S. ; Nekljudova, V. ; Szucs, T.D. ; Van Stiphout, J. ; Ademi, Z. ; von Minckwitz, G. ; Schwenkglenks, M.

In: Annals of Oncology, 2015, vol. 26, p. iii16-iii17

Ajouter à la liste personnelle
    Titre
    • 45PCost-effectiveness analysis of VEGF-A testing to predict response to bevacizumab (BEV) as a component of neo-adjuvant therapy of early HER-2 negative breast cancer
    Auteur
    • Blank, P.R.. European Center of Pharmaceutical Medicine (ECPM), University of Basel Institute of Pharmaceutical Medicine, Basel, Switzerland
    • Loibl, S.. Medicine and Research, German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany
    • Linderholm, B.K.. Department of Oncology/Pathology, Karolinska University Hospital and Karolinska Institute-Huddinge, Stockholm, Sweden
    • Caramuta, S.. Department of Oncology/Pathology, Karolinska University Hospital and Karolinska Institute-Huddinge, Stockholm, Sweden
    • Nekljudova, V.. Medicine and Research, German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany
    • Szucs, T.D.. European Center of Pharmaceutical Medicine (ECPM), University of Basel Institute of Pharmaceutical Medicine, Basel, Switzerland
    • Van Stiphout, J.. European Center of Pharmaceutical Medicine (ECPM), University of Basel Institute of Pharmaceutical Medicine, Basel, Switzerland
    • Ademi, Z.. European Center of Pharmaceutical Medicine (ECPM), University of Basel Institute of Pharmaceutical Medicine, Basel, Switzerland
    • von Minckwitz, G.. Medicine and Research, German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany
    • Schwenkglenks, M.. European Center of Pharmaceutical Medicine (ECPM), University of Basel Institute of Pharmaceutical Medicine, Basel, Switzerland
    Type de document
    • Postprint
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:302675